Annals of Clinical and Translational Neurology

Article	Citations
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia	117
The case of a 49‐year‐old man with involuntary toe movements	103
Issue Information	79
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights	69
The Case of a 25‐Year‐Old Woman With Isolated Head Tremor	67
Discrepant expressive language lateralization in children and adolescents with epilepsy	62
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐ AChR Antibody‐	61
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	61
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	49
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	44
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	44
Order from chaos: Using CSF proteomics to predict ALS progression	43
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	43
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury	42
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	42
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	41
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab	40
Association of serum Spp1 levels with disease progression in ALS and SBMA	40
SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis	40
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	39
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	39
Peripheral nervous system manifestations of MOG antibody associated disease	39
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	38
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	37
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	37

Cognitive impairment in pulmonary arterial hypertension	37
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	36
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	36
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability	35
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	35
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D	35
Predictors of mTICI 2c/3 over 2b in patients successfully recanalized with mechanical thrombectomy	34
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	34
Issue Information	34
Corrigendum: Genome sequencing in persistently unsolved white matter disorders	33
Dose–exposure–efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy	33
The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment	33
Expanding Hereditary Spastic Paraplegias Limits: Biallelic SPAST Variants in Cerebral Palsy Mimics	32
Correlation of slow‐wave sleep with motor and nonmotor progression in Parkinson's disease	32
Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis	32
Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study	32
The Case of a 28‐Year‐Old Woman With Medically Refractory Focal Epilepsy	31
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone	31
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)	31
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience	31
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis	30
Cerebellar impulsivity–compulsivity assessment scale	30
Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review	30
Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study	29
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons	29
Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers	29
Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy	29
Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study	28
Visceral and emotional responses to direct electrical stimulations of the cortex	28
A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression	28
Prolonged venous transit is associated with worse neurological recovery in successfully reperfused large vessel strokes	27
Exosomal circ‐AHCY promotes glioblastoma cell growth via Wnt/β‐catenin signaling pathway	27
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention	26
Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease	26
Intracranial plaque with large lipid core is associated with embolic stroke of undetermined source	26
Progressive Myoclonus Epilepsy: Distinctive MRI Changes in Cerebellar and Motor Networks	25
Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study	25
Issue Information	25
Horizontal gaze palsy with progressive scoliosis: Further expanding the ROBO3 spectrum	25
Issue Information	25
Issue Information	24
Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics	24
Characteristics of Cerebral Palsy in the Midwestern US	24
Issue Information	24
Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria	23
RETRACTION: α‐Synuclein Conformational Antibodies Fused to Penetratin are Effective in Models of Lewy Body Disease	23
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease	23
Epidural stimulation with locomotor training ameliorates unstable blood pressure after tetraplegia. A case report	23
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling	23
Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting	23

Cortical networks of parkinsonian gait: a metabolic and functional connectivity study	22
Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning	22
COVID‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis	22
Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis	22
CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity	22
The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis	21
TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function	21
Retina as a potential biomarker for the early stage of Alzheimer's disease spectrum	21
Transcranial pulse stimulation in the treatment of mild neurocognitive disorders	21
Issue Information	21
Laser interstitial thermal therapy in the management of bottom‐of‐sulcus dysplasia‐related epilepsy	21
Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2‐allelic disorders	21
Circulating Interleukin‐6 Levels and Timing of Acute Ischemic Stroke Onset	21
Altered Dynamic Functional Network Connectivity in Post‐Stroke Aphasia	20
The case of an 85‐year‐old female with acute right hemiparesis with status epilepticus	20
A PANoptosis‐Based Signature for Survival and Immune Predication in Glioblastoma Multiforme	20
Modifiable factors associated with Huntington's disease progression in presymptomatic participants	20
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy	20
Voxel‐based dysconnectomic brain morphometry with computed tomography in Down syndrome	19
Cerebello‐Prefrontal Connectivity Underlying Cognitive Dysfunction in Spinocerebellar Ataxia Type 2	19
Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy	19
A novel autosomal dominant ERLIN2 variant activates endoplasmic reticulum stress in a Chinese HSP family	19
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease	19
Temporal lobe epilepsy surgery: Piriform cortex resection impacts seizure control in the long‐term	19
Intravenous tirofiban following successful reperfusion in intracranial large artery atherosclerotic stroke: A secondary analysis of a randomized clinical trial	19
Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis	19
Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis	19
The Case of a 37‐Year‐Old Woman Presenting With Subacute Weakness and Paresthesias	19
Effects of Non‐Aspirin Nonsteroidal Anti‐Inflammatory Drugs on Acute Intracerebral Hemorrhage	18
Quantity and Volume of Perivascular Spaces Are Inversely Associated With Multiple Sclerosis Relative to Cerebrovascular Disease and Migraine	18
Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia	18
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis	18
The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials	18
Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome	18
Machine learning models for outcome prediction in thrombectomy for large anterior vessel occlusion	18
Comparison of plasma and CSF biomarkers in predicting cognitive decline	18
A machine learning approach to predict quality of life changes in patients with Parkinson's Disease	18
Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy	18
Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features	18
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing	18
Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study	18
Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease	17
RETRACTION: Mechanism of ARPP21 antagonistic intron miR‐128 on neurological function repair after stroke	17
	17
	17
Longitudinal serum neurofilament light kinetics in post‐anoxic encephalopathy	17
Issue Information	17
Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis	17
Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event	17
Mutation and clinical analysis of the CLCC1 gene in amyotrophic lateral sclerosis patients from Central South China	17
Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”	17
NR4A1 Exerts Pro‐Tumor Role in Glioblastoma via Inducing xCT/GPX4‐Regulated Ferroptosis	17
Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy	17
Benchmarking the proteomic profile of animal models of mesial temporal epilepsy	16
Mitochondrial dysfunction in brain tissues and Extracellular Vesicles Fragile X‐associated tremor/ataxia syndrome	16
CIDP/autoimmune nodopathies with nephropathy: a case series study	16
Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities	16
Lesion Location and Functional Connections Reveal Cognitive Impairment Networks in Multiple Sclerosis	16
Non‐neurological factors associated with serum neurofilament levels in the United States population	16
Remyelination varies between and within lesions in multiple sclerosis following bexarotene	16
Power training alters somatosensory cortical activity of youth with cerebral palsy	16
Nanopore 16S sequencing enhances the detection of bacterial meningitis after neurosurgery	16
Persistent Leukoencephalopathy Following H 1 N 1 Infection Associated With a Novel	16
A different pattern of clinical, muscle pathology and brain MRI findings in MELAS with mt‐ND variants	16
Infliximab in neurosarcoidosis: a systematic review and meta‐analysis	15
Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL	15
Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset	15
A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's	15
Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy	15
Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a “real‐world” setting	15
Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies	15
After early mTICI 2b, stop or continue? Insights from the PERSIST Registry	15
Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy	15
	15
Innovative technology‐based interventions in Parkinson's disease: A systematic review and meta‐analysis	15
	15
Upregulation of RCAN1.4 by HIF1α alleviates OGD‐induced inflammatory response in astrocytes	15
Chitotriosidase is a biomarker for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia	15
Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia	15
LRRK2 and Parkinson's disease: from genetics to targeted therapy	15

Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis	15
Argatroban plus alteplase in posterior versus anterior circulation stroke	14
Odor identification predicts the transition of patients with isolated RBD: A retrospective study	14
Optical genome mapping: Unraveling complex variations and enabling precise diagnosis in dystrophinopathy	14
Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis	14
Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care	14
Evaluation of the Efficacy and Safety of Satralizumab in a Pregnant NMOSD Patient With AQP4 /	14
The Road Not Taken: Misclassifying an Anti‐Seizure Medication as a Failure	14
Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”	14
Refractory Status Epilepticus Treated With Bilateral Pulvinar Deep Brain Stimulation—A Case Study	14
Exploring if Longitudinal Changes on PET Imaging Can Serve as a Biomarker for Stiff Person Syndrome Spectrum Disorders	14
Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study	14
Patient Selection in Deep Brain Stimulation: A Role for Transcranial Direct Current Stimulation to Enhance the Levodopa Challenge?	14
Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy	14
Observational study of medical marijuana as a treatment for treatment‐resistant epilepsies	14
Dorsolateral Cervical Cord T2 Hyperintensity in KIF1C	14
Bilateral versus Unilateral Training With Rhythmic Auditory Cueing in Stroke Rehabilitation: Effects on Upper Limb Function and Interhemispheric Inhibition	14
A machine‐learning approach for predicting impaired consciousness in absence epilepsy	14
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers	13
4‐Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders	13
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI‐1601) in Friedreich's ataxia	13
Life‐Threatening Bradycardia in Anti‐ NMDA ‐Receptor Encephalitis and a Novel Use for Permanent Pacing	13
Long‐term safety and efficacy of stenting on correcting internal jugular vein and cerebral venous sinus stenosis	13
Scientific rationale for a higher dose of nusinersen	13
Pupillary dynamics predict long‐term outcome in a cohort of acute traumatic brain injury coma patients	13
Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy	13
“Brain age” predicts disability accumulation in multiple sclerosis	13
Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL	12
Prediction of Myasthenia Gravis Worsening: A Machine Learning Algorithm Using Wearables and Patient‐Reported Measures	12
Sensitivity and specificity of the Salzburg EEG criteria for nonconvulsive status epilepticus	12
The Impact of Tilburg Frailty on Poststroke Fatigue in First‐Ever Stroke Patients: A Cross‐Sectional Study With Unified Measurement Tools and Improved Statistics	12
Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets	12
Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder	12
Heart meets brain: A 25‐year‐old with a constellation of neurologic symptoms and heart failure	12
Novel Phenotypes and Deep Intronic Variant Expand TH‐Associated Dopa‐Responsive Dystonia Spectrum	12
Baseline systolic blood pressure, hypertension history, and efficacy of remote ischemic conditioning	12
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum	12
Psychotropic medication use and Parkinson's disease risk amongst older women	12
B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity	12
Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective	12
T1−/T2‐weighted ratio reveals no alterations to gray matter myelination in temporal lobe epilepsy	12
Correction to “Efgartigimod for Generalized Myasthenia Gravis: A Multicenter Real‐World Cohort Study in China”	12
Lipid levels and the risk of dementia: A dose–response meta‐analysis of prospective cohort studies	12
Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis	12
Portable Low‐Field Magnetic Resonance Imaging in People With Human Immunodeficiency Virus	12
Neurological diagnoses in hospitalized COVID‐19 patients during the B.1.1.529 surge	12
WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy	12
Frailty Exacerbates Disability in Progressive Multiple Sclerosis	11
Women's reproductive traits and ischemic stroke: a two‐sample Mendelian randomization study	11
Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report	11
Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank	11
An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis	11
First‐ever acute ischemic strokes in HIV‐infected persons: A case–control study from stroke units	11
Impact of lipid profiles on parenchymal hemorrhage and early outcome after mechanical thrombectomy	11
Erratum to “Inferring Disease Course From Differential Exon Usage in the Wide Titinopathy Spectrum”	11
Psoriasis and dementia: A population‐based matched cohort study of adults in England	11
CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM	11
	11
Optimized microburst VNS elicits fMRI responses beyond thalamic‐specific response from standard VNS	11
SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder	11
Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease	11
Long COVID in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross‐Sectional Study	11
Chronological and Spatial Distribution of Skeletal Muscle Fat Replacement in FHL1‐Related Myopathies	11
Association of the time of day of EVT with clinical outcomes and benefit from successful recanalization after stroke	11
Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study	11
Issue Information	11
Disorder of consciousness: Structural integrity of brain networks for the clinical assessment	11
Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis	11
Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue	11
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome	11
Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY‐associated diseases	11
B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy	11
Genetic spectrum in a cohort of patients with distal hereditary motor neuropathy	11
Cortical signature of depressive symptoms in frontotemporal dementia: A surface‐based analysis	11
White matter microstructures in Parkinson's disease with and without impulse control behaviors	11
Adult‐onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?	10
Homozygous variant in COQ7 causes autosomal recessive hereditary spastic paraplegia	10
Music Interventions in Hyperacute and Acute Stroke Patients: A Randomized Controlled Pilot Feasibility Study	10
The neural correlates of topographical disorientation—a lesion analysis study	10
Combination disease‐modifying treatment in spinal muscular atrophy: A proposed classification	10
Efficacy and safety of combined low‐dose rituximab regimen for chronic inflammatory demyelinating polyradiculoneuropathy	10
The McCance Brain Care Score and Mortality: Evidence From a Large‐Scale Population‐Based Cohort	10
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis	10
Does long‐term phenytoin have a place in Dravet syndrome?	10
Mutations in the tail and rod domains of the neurofilament heavy‐chain gene increase the risk of ALS	10
Axonal injury, sleep disturbances, and memory following traumatic brain injury	10
Using chronic recordings from a closed‐loop neurostimulation system to capture seizures across multiple thalamic nuclei	10
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia	10
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population	10
Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)	10
Amyloidogenicity assessment of transthyretin gene variants	10
Observational Study of Tocilizumab in Children With Febrile Infection‐Related Epilepsy Syndrome	10
The Diverse Neuromuscular Spectrum of VPS13A Disease	10
Increased Blood Levels of NfL , GFAP , and Placental Growth Factor After Radiotherapy to the Brain	10
Remaining Burden of Spinal Muscular Atrophy Among Treated Patients: A Survey of Patients and Caregivers	10